Vanberra Signal

Genomic Health

Curated by Signal

Genomic-based diagnostic tests for cancer

Overview

Genomic-based diagnostic tests for cancer. The company uses algorithms to analyze gene expression data and to arrive at a prognosis score for different types of cancer. Its flagship product is the OncotypeDx for Breast cancer that provides a risk of recurrence in breast cancer patients suffering post-surgery. In addition, Genomic Health also has OncotypeDx tests for prostate cancer and colon cancer.

Key facts

Founded
2000

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Provider of DNA Sequencing for identification of pathogens and antibiotic resistances in dogs

    Life Sciences TechnologyIrvine, United States
  • Pressure catheters used to measure hemodynamic parameters of the heart

    Life Sciences TechnologyHouston, United States
  • Provider of medical equipment for hospitals

    Life Sciences TechnologyNew York City, United States

About Genomic Health

What does Genomic Health do?

Genomic-based diagnostic tests for cancer.

Where is Genomic Health headquartered?

Genomic Health is headquartered in Redwood City, United States.

When was Genomic Health founded?

Genomic Health was founded in 2000.

Which sector is Genomic Health in?

Genomic Health operates in Life Sciences Technology.

Who are Genomic Health's competitors?

Companies similar to Genomic Health include MiDOG, Millar, and Gradian Health Systems.